According to Innate Pharma 's latest financial reports the company's current revenue (TTM) is $53.09 M. In 2022 the company made a revenue of $53.09 M an increase over the years 2021 revenue that were of $13.71 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 | $53.09 M | 287.17% |
2021 | $13.71 M | -80.14% |
2020 | $69.07 M | -10.13% |
2019 | $76.85 M | -15.91% |
2018 | $91.39 M | 133.31% |
2017 | $39.17 M | -33.74% |
2016 | $59.11 M | 201.96% |
2015 | $19.57 M | 1674.86% |
2014 | $1.1 M | -93.59% |
2013 | $17.21 M | 25.45% |
2012 | $13.72 M | 42.09% |
2011 | $9.66 M | 68.12% |
2010 | $5.74 M | -48.02% |
2009 | $11.05 M | -38.81% |
2008 | $18.06 M | -13.41% |
2007 | $20.86 M | 86.2% |
2006 | $11.2 M | 288% |
2005 | $2.88 M |